Table-IV.
Sexual hormone and CA125 levels (x ± s) (n=50).
| Group | FSH (U/L) | E2 (ng/L) | LH (U/L) | CA125 (U/ml) | ||||
|---|---|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
| A | 5.66±1.29 | 2.40±0.67# | 180.96±24.78 | 96.81±9.75 # | 6.82±1.53 | 2.52±0.61 # | 54.71±8.44 | 24.18±4.30 # |
| B | 5.52±1.25 | 3.94±0.95*# | 182.77±25.43 | 154.42±18.03*# | 6.71±1.49 | 3.94±0.95*# | 53.53±8.29 | 36.86±6.38*# |
| C | 5.81±1.20 | 3.89±0.71*# | 180.23±24.93 | 157.52±17.89*# | 6.81±1.51 | 3.89±0.71*# | 55.21±8.32 | 35.84±6.91*# |
Compared with Group-A,
*
P<0.05; compared with scores before treatment,
#
P<0.05.